Synthesis and biological evaluation of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine derivatives for PNP-inhibitors. 2006

Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
School of Pharmacy, Tokyo University of Pharmacy and Life Science, Japan.

9-(5',5'-Difluoro-5'-phosphonopentyl)guanine (DFPP-G) and its hypoxanthine analogue (DFPP-H) were modified by introducing a methyl group to all possible positions of the linker connecting a purine and difluoromethylenephosphonic acid moiety to evaluate the effects of the methyl group on inhibition against purine nucleoside phosphorylase. The methyl group on the linker affected the inhibition in a positional-dependent manner. Inhibitory potency of alpha-methyl and beta-methyl-substituted analogues of DFPP-H increased by about 600- to 1000-fold upon converting to cyclopropane nucleotide analogue (+/-)-4.

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D010756 Phosphoric Acids Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES. Pyrophosphoric Acids,Acids, Phosphoric,Acids, Pyrophosphoric
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004002 Clodronic Acid A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. Clodronate,Dichloromethylene Diphosphonate,Bonefos,Cl2MDP,Clodronate Disodium,Clodronate Sodium,Dichloromethane Diphosphonate,Dichloromethanediphosphonate,Dichloromethanediphosphonic Acid,Dichloromethylene Biphosphonate,Dichloromethylenebisphosphonate,Acid, Clodronic,Acid, Dichloromethanediphosphonic,Biphosphonate, Dichloromethylene,Diphosphonate, Dichloromethane,Diphosphonate, Dichloromethylene,Disodium, Clodronate,Sodium, Clodronate
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005459 Fluorides Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices. Fluoride
D006147 Guanine

Related Publications

Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
January 2007, Nucleic acids symposium series (2004),
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
January 2015, Nucleosides, nucleotides & nucleic acids,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
August 2007, Bioorganic & medicinal chemistry letters,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
August 2002, Bioorganic & medicinal chemistry letters,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
January 2015, Chemical & pharmaceutical bulletin,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
September 2019, European journal of medicinal chemistry,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
April 2015, Bioorganic & medicinal chemistry letters,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
January 2022, Frontiers in chemistry,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
May 2007, Bioorganic & medicinal chemistry letters,
Sadao Hikishima, and Machiko Isobe, and Satoru Koyanagi, and Shinji Soeda, and Hiroshi Shimeno, and Shiroshi Shibuya, and Tsutomu Yokomatsu
June 2012, Molecules (Basel, Switzerland),
Copied contents to your clipboard!